Keyphrases
Narrative Review
100%
Epigenomics
100%
Transcriptomics
100%
Gallbladder Cancer
100%
Patient Management
16%
Therapeutic Target
16%
Molecular Mechanism
16%
Oncogenesis
16%
Management Strategy
16%
RNA Sequencing (RNA-seq)
16%
Overall Survival
16%
Surgical Resection
16%
Molecular Biomarkers
16%
Epigenetics
16%
Transcriptome Profile
16%
Poor Prognosis
16%
Malignant Neoplasms
16%
Diagnostic Biomarker
16%
Clinical Course
16%
Advanced Disease
16%
Technological Progress
16%
Pathological Examination
16%
Cancer Diagnosis
16%
Death Rate
16%
Cellular Heterogeneity
16%
Surgical Therapy
16%
Biliary Tract
16%
Microarray Technology
16%
Routine Screening
16%
Personalized Therapy
16%
Cholecystectomy
16%
Gallbladder
16%
Next-generation Sequencing
16%
High-throughput Sequencing
16%
Imaging Investigations
16%
Single-cell Sequencing Technology
16%
Personalized Management
16%
Epigenomic Profile
16%
Cell Microarray
16%
Molecular Platforms
16%
Biochemistry, Genetics and Molecular Biology
Epigenomics
100%
Epigenetics
100%
Transcriptomics
100%
Epigenetics
50%
Genetics
50%
Carcinogenesis
50%
RNA Sequence
50%
Microarrays
50%
Mortality Rate
50%
Overall Survival
50%
Gene Expression Profiling
50%
Next Generation Sequencing
50%
High Throughput Sequencing
50%
Genomics
50%
Medicine and Dentistry
Epigenomics
100%
Transcriptomics
100%
Gallbladder Cancer
100%
Surgery
33%
Biological Marker
33%
Malignant Neoplasm
16%
Disease
16%
Carcinogenesis
16%
Diagnosis
16%
Patient Care
16%
RNA Sequence
16%
Gene Expression Profiling
16%
Overall Survival
16%
Disease Course
16%
Personalized Medicine
16%
Clinical Stage
16%
Mortality Rate
16%
Cancer Diagnosis
16%
Next Generation Sequencing
16%
Hepatobiliary System
16%
Cholecystectomy
16%
Immunology and Microbiology
Transcriptomics
100%
Epigenetics
100%
Gall Bladder
100%
RNA Sequence
14%
Mortality Rate
14%
Overall Survival
14%
Hepatobiliary System
14%
Next Generation Sequencing
14%
High Throughput Sequencing
14%
Single-Cell Sequencing
14%
Gene Expression Assay
14%
Pharmacology, Toxicology and Pharmaceutical Science
Gallbladder Cancer
100%
Biological Marker
33%
Malignant Neoplasm
16%
Disease
16%
RNA-Sequencing
16%
Overall Survival
16%
Mortality Rate
16%
Disease Course
16%
Carcinogenesis
16%